MDT vs ABT
MDT and ABT side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MDTMedtronic plc | ABTABBOTT LABORATORIES |
|---|---|---|
| Market cap | $127.02B | $192.09B |
| P/E (TTM) | 24.5 | 30.9 |
| P/B | 2.53 | 3.69 |
| P/S | 3.4x | 4.3x |
| Dividend yield | 2.86% | 2.14% |
| Revenue | $37.54B(TTM) | $45.13B(TTM) |
| Revenue growth (YoY) | 8.4% | 5.7% |
| Net income | $430.00M(TTM) | $6.28B(TTM) |
| Earnings growth (YoY) | 3.0% | -51.3% |
| EPS, diluted | $4.06(TTM) | $3.57(TTM) |
| EBIT margin | 17.8% | 18.2% |
| ROE | 0.0% | 12.5% |
| ROIC | 7.0% | 8.3% |
| Piotroski F | 8/9 | — |
| 1y total return | +10.7% | -10.3% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: MDT frente a ABT
| Métrica | MDT | ABT |
|---|---|---|
| Valor final | $14.7K | $34.2K |
| Retorno total | +47.3% | +242.4% |
| CAGR | +3.8% | +12.6% |
| Volatilidad | 23.4% | 23.9% |
| Sharpe | 0.10 | 0.44 |
| Sortino | 0.14 | 0.63 |
| Caída máxima | -45.3% | -39.6% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.21% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)